Get started
Author

Patrizia Perazzo

Observed names: P Perazzo, P. Perazzo
ORCID: 0009-0009-5541-3201
Observed ORCID: 0009-0009-5541-3201
OpenAlex ID: A5082861393
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
2022 · Antonio Tursi, Giammarco Mocci, et al. · Inflammatory Bowel Diseases · 33
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study.
2021 · A Tursi, G Mocci, et al. · PubMed · 19
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy
2022 · Antonio Tursi, Giammarco Mocci, et al. · Journal of Gastrointestinal and Liver Diseases · 16
PDF
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study
2023 · Giammarco Mocci, Antonio Tursi, et al. · Expert Opinion on Biological Therapy · 14
Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
2022 · Giammarco Mocci, Giorgia Bodini, et al. · Biomedicines · 13
PDF
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study
2024 · Giammarco Mocci, Antonio Tursi, et al. · Journal of Clinical Medicine · 10
PDF
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study
2025 · Antonio Tursi, Giammarco Mocci, et al. · Intestinal Research · 4
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy
2021 · Antonio Tursi, Giammarco Mocci, et al. · Expert Opinion on Biological Therapy · 3
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis
2011 · Francesco Di Mario, Massimo Rugge, et al. · Gastroenterology · 3
PDF
Use of Methotrexate in Children and Young Adults Affected by Ulcerative Colitis: A Retrospective Study
2011 · Alessia Ghiselli, Cristina Calzolari, et al. · The American Journal of Gastroenterology · 2
Pp10 Mallory-weiss Syndrome in Children: Rare Complication of Eosinophilic Gastroenteritis
2011 · P. Soriani, B. Bizzarri, et al. · Digestive and Liver Disease · 1
Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study
2026 · Antonio Tursi, Giammarco Mocci, et al. · American Journal of Therapeutics
T.06.4 Filgotinib Effectiveness and Safety as Second or Thirdline Therapy in Patients With Ulcerative Colitis: Data From a Real-world Study
2025 · G. Mocci, F. Costa, et al. · Digestive and Liver Disease
P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort study
2021 · G Mocci, A Cuomo, et al. · Journal of Crohn s and Colitis
Late Extrahepatic Recurrence of Hepatocellular Carcinoma after Liver Transplantation: A Rare Case Report and Literature Review
2016 · Riccardo Solimando, Gian Maria Prati, et al. · Journal of Gastroenterology and Hepatology Research
PDF
P.17.18 Efficacy and Safety of Endoscopic Management of Oesophageal Strictures
2013 · P. Soriani, P. Perazzo, et al. · Digestive and Liver Disease
Co3 Endoscopic Treatment of Esophageal Varices
2012 · P. Perazzo, F. Fornaroli, et al. · Digestive and Liver Disease
Efficacy and Safety of Endoscopic Management of Esophageal Strictures in Children
2012 · Alessia Ghiselli, Barbara Bizzarri, et al. · The American Journal of Gastroenterology
Pp58 Presentation of Crohn's Disease Like Duodenal Ulcers – Report of Three Cases
2011 · P. Perazzo, B. Bizzarri, et al. · Digestive and Liver Disease
Multiple Intraluminal Impedance (MII) as Diagnostic Gold Standard for Children with Respiratory Symptoms Due to Atypical Gastroesophageal Reflux Disease (GERD)
2011 · Francesca Vincenzi, Carmen Madia, et al. · The American Journal of Gastroenterology
Pepsinogen I, II, Ratio, and G-17 in Patients With Esophagitis and Patients With Extra-Esophageal Manifestations of GERD
2011 · Francesco Di Mario, Luigi Gatta, et al. · Gastroenterology
PDF
P.1.325: Usefulness of Serum Pepsinogens to Identify Chronic Atrop H Ic Gastritis
2011 · A. Iori, L. Gatta, et al. · Digestive and Liver Disease
P.1.288: Pepsinogen I, Ii, Ratio, and G-17 in Patients With Esophagitis and Patients With Extra-esophageal Manifestations of Gerd
2011 · P. Perazzo, L. Gatta, et al. · Digestive and Liver Disease
P.10 “gastropanel Test” in the Clinical Outcome of Gerd: Prospective Six Months Clinical Study
2010 · L. Guida, P. Perazzo, et al. · Digestive and Liver Disease
Works count: 24
Citation count: 118
H-index: 6
I10-index: 6
Year
Topic
Type